Mengxiao Yu
Principal investigator.
Medtech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2017First federal award
$5.2MFederal grants as PI9 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
9 awards · $5.2M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Aug 8, 2024 | NIH | SBIR Phase II Advancing Fluorescence Imaging-guided Partial Nephrectomy with ClearICG | $1.1M | CLEARNANO INC |
| Sep 7, 2023 | NIH | SBIR Phase II Advancing Fluorescence Imaging-guided Partial Nephrectomy with ClearICG | $852K | CLEARNANO INC |
| Sep 1, 2023 | NIH | SBIR Phase II Advancing Fluorescence Imaging-guided Partial Nephrectomy with ClearICG | $852K | CLEARNANO INC |
| Aug 3, 2022 | NIH | STTR Phase II STTR Phase II: Advance Early Detection of Lupus Nephritis with ClearGold | $605K | CLEARNANO INC |
| Sep 24, 2021 | NIH | STTR Phase II STTR Phase II: Advance Early Detection of Lupus Nephritis with ClearGold | $810K | CLEARNANO INC |
| Sep 23, 2021 | NIH | SBIR Phase II Advancing Fluorescence Imaging-guided Partial Nephrectomy with ClearICG | $385K | CLEARNANO INC |
| Sep 19, 2019 | NIH | STTR Phase I Advance Early Detection of Lupus Nephritis with ClearGold | $288K | CLEARNANO INC |
| Sep 10, 2018 | NIH | SBIR Phase I Renal clearable NIR-emitting gold nanoparticles for early detection of drug-induced nephrotoxicity | $30K | CLEARNANO INC |
| Sep 18, 2017 | NIH | SBIR Phase I Renal clearable NIR-emitting gold nanoparticles for early detection of drug-induced nephrotoxicity | $225K | CLEARNANO INC |
Peer ranks
Federal funding#270
Awards as PI#166
Patents#505
Companies
- CLEARNANO INCLinked by awards · Medtech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.